AstaLynx Global Signs Multi-Year Contract with Biopharmaceutical for Drug Safety Technology Adoption and Implementation ...Middle East

NEW YORK, May 3, 2022 /PRNewswire/ -- AstaLynx Global today announced the agreement with a midsize biopharmaceutical company to centralize their mission critical Pharmacovigilance activities. The biopharmaceutical will adopt and implement the full suite of AstaLynx's proprietary Drug...

Hence then, the article about astalynx global signs multi year contract with biopharmaceutical for drug safety technology adoption and implementation was published today ( Tuesday 03/05/2022 - 07:42 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AstaLynx Global Signs Multi-Year Contract with Biopharmaceutical for Drug Safety Technology Adoption and Implementation )

Also on site :

• INCERGO S.A. PROGRESSION DE LA FUSION AVEC VISUAL SEMICONDUCTOR PAR L'ÉMISSION D'ACTIONS ET PRÉSENTATION D'ÉCRANS 3D SANS LUNETTE AU SALON DE L'ÉLECTRONIQUE GRAND PUBLIC DE LAS VEGAS
• Nigeria: Govt Unveils 2026 Economic Growth Agenda, Set to Prioritise Jobs, Investments
• Russia’s Sanctioned LNG Finds a Growing Market in China